Select Publications

Journal articles

McDermid P; Blazek K; Mougin N; Thomson A; Seale H, 2024, 'Attitudes and behaviors of maternal Tdap vaccination in Panama, Peru, and Colombia: An international cross-sectional study.', Vaccine,

Tran JK; Ooi CY; Blazek K; Katz T, 2023, 'Body composition and body mass index measures from 8 to 18 years old in children with cystic fibrosis', Journal of Cystic Fibrosis, 22, pp. 851 - 856,

Scholes-Robertson N; Blazek K; Tong A; Gutman T; Craig JC; Essue BM; Howard K; Wong G; Howell M, 2023, 'Financial toxicity experienced by rural Australian families with chronic kidney disease', Nephrology, 28, pp. 456 - 466,

McDermid P; Craig A; Sheel M; Blazek K; Talty S; Seale H, 2023, 'Information seeking behaviors of individuals impacted by COVID-19 international travel restrictions: an analysis of two international cross-sectional studies', Frontiers in Communication, 8,

Khalid R; Van Zwieten A; Kim S; Didsbury M; Francis A; Mctaggart S; Walker A; Mackie FE; Prestidge C; Teixeira-Pinto A; Barton B; Lorenzo J; Lah S; Howard K; Nassar N; Au E; Tong A; Blazek K; Craig JC; Wong G, 2022, 'Association between socioeconomic status and academic performance in children and adolescents with chronic kidney disease', Pediatric Nephrology, 37, pp. 3195 - 3204,

Blazek K; Furestad E; Ryan D; Damian D; Fernandez-Penas P; Tong S, 2022, 'The impact of skin cancer prevention efforts in New South Wales, Australia: Generational trends in melanoma incidence and mortality', Cancer Epidemiology, 81,

Kim S; Van Zwieten A; Lorenzo J; Khalid R; Lah S; Chen K; Didsbury M; Francis A; Mctaggart S; Walker A; Mackie FE; Prestidge C; Teixeira-Pinto A; Tong A; Blazek K; Barton B; Craig JC; Wong G, 2022, 'Cognitive and academic outcomes in children with chronic kidney disease', Pediatric Nephrology, 37, pp. 2715 - 2724,

Chung EYM; Blazek K; Teixeira-Pinto A; Sharma A; Kim S; Lin Y; Keung K; Bose B; Kairaitis L; McCarthy H; Ronco P; Alexander SI; Wong G, 2022, 'Predictive Models for Recurrent Membranous Nephropathy after Kidney Transplantation', Transplantation Direct, 8, pp. E1357,

McDermid P; Sooppiyaragath S; Craig A; Sheel M; Blazek K; Talty S; Seale H, 2022, 'Psychological and financial impacts of COVID-19-related travel measures: An international cross-sectional study', PLoS ONE, 17,

Lalji R; Francis A; Blazek K; Teixeira-Pinto A; Wong G; Johnson DW, 2022, 'Sex differences in the likelihood of pre-emptive living donor kidney transplantation, and outcomes after kidney transplantation in children and adolescents', Pediatric Transplantation, 26,

McDermid P; Craig A; Sheel M; Blazek K; Talty S; Seale H, 2022, 'Examining the psychological and financial impact of travel restrictions on citizens and permanent residents stranded abroad during the COVID-19 pandemic: International cross-sectional study', BMJ Open, 12,

Urriola N; Blazek K; Adelstein S, 2022, 'Subunit-specific autoantibodies in autoimmune autonomic ganglionopathy', Journal of Neuroimmunology, 363,

Urriola N; Spies JM; Blazek K; Lang B; Adelstein S, 2021, 'A Flow Cytometric Assay to Detect Functional Ganglionic Acetylcholine Receptor Antibodies by Immunomodulation in Autoimmune Autonomic Ganglionopathy', Frontiers in Immunology, 12,

Ord TJ; Blazek K; White TE; Das I, 2021, 'Conspicuous animal signals avoid the cost of predation by being intermittent or novel: Confirmation in the wild using hundreds of robotic prey', Proceedings of the Royal Society B: Biological Sciences, 288,

Houssami N; Zackrisson S; Blazek K; Hunter K; Bernardi D; Lång K; Hofvind S, 2021, 'Meta-analysis of prospective studies evaluating breast cancer detection and interval cancer rates for digital breast tomosynthesis versus mammography population screening', European Journal of Cancer, 148, pp. 14 - 23,

Sinka V; Lopez-Vargas P; Tong A; Dickson M; Kerr M; Sheerin N; Blazek K; Teixeira-Pinto A; Stephens JH; Craig JC, 2021, 'Chronic disease prevention programs offered by Aboriginal Community Controlled Health Services in New South Wales, Australia', Australian and New Zealand Journal of Public Health, 45, pp. 59 - 64,

Blazek K; van Zwieten A; Saglimbene V; Teixeira-Pinto A, 2021, 'A practical guide to multiple imputation of missing data in nephrology', Kidney International, 99, pp. 68 - 74,

Standen JC; Morgan GG; Sowerbutts T; Blazek K; Gugusheff J; Puntsag O; Wollan M; Torzillo P, 2020, 'Prioritising housing maintenance to improve health in indigenous communities in NSW over 20 years', International Journal of Environmental Research and Public Health, 17, pp. 1 - 22,

Francis A; Johnson DW; Melk A; Foster BJ; Blazek K; Craig JC; Wong G, 2020, 'Survival after kidney transplantation during childhood and adolescence', Clinical Journal of the American Society of Nephrology, 15, pp. 392 - 400,

Reece LJ; McInerney C; Blazek K; Foley BC; Schmutz L; Bellew B; Bauman AE, 2020, 'Reducing financial barriers through the implementation of voucher incentives to promote children's participation in community sport in Australia', BMC Public Health, 20,

Hair K; Macleod MR; Sena ES, 2019, 'A randomised controlled trial of an Intervention to Improve Compliance with the ARRIVE guidelines (IICARus)', RESEARCH INTEGRITY AND PEER REVIEW, 4,

Bauman AE; Blazek K; Reece L; Bellew W, 2018, 'The emergence and characteristics of the Australian mamil', Medical Journal of Australia, 209, pp. 490 - 494,

Weiss M; Byrne AJ; Blazek K; Saliba DG; Pease JE; Perocheau D; Feldmann M; Udalova IA, 2015, 'IRF5 controls both acute and chronic inflammation', Proceedings of the National Academy of Sciences of the United States of America, 112, pp. 11001 - 11006,

Dalmas E; Toubal A; Alzaid F; Blazek K; Eames HL; Lebozec K; Pini M; Hainault I; Montastier E; Denis RGP; Ancel P; Lacombe A; Ling Y; Allatif O; Cruciani-Guglielmacci C; André S; Viguerie N; Poitou C; Stich V; Torcivia A; Foufelle F; Luquet S; Aron-Wisnewsky J; Langin D; Clément K; Udalova IA; Venteclef N, 2015, 'Irf5 deficiency in macrophages promotes beneficial adipose tissue expansion and insulin sensitivity during obesity', Nature Medicine, 21, pp. 610 - 618,

Blazek K; Eames HL; Weiss M; Byrne AJ; Perocheau D; Pease JE; Doyle S; McCann F; Williams RO; Udalova IA, 2015, 'IFN-λ resolves inflammation via suppression of neutrophil infiltration and IL-1β production', Journal of Experimental Medicine, 212, pp. 845 - 853,

McCann FE; Perocheau DP; Ruspi G; Blazek K; Davies ML; Feldmann M; Dean JLE; Stoop AA; Williams RO, 2014, 'Selective tumor necrosis factor receptor i blockade is antiinflammatory and reveals immunoregulatory role of tumor necrosis factor receptor II in collagen-induced arthritis', Arthritis and Rheumatology, 66, pp. 2728 - 2738,

Saliba DG; Heger A; Eames HL; Oikonomopoulos S; Teixeira A; Blazek K; Androulidaki A; Wong D; Goh FG; Weiss M; Byrne A; Pasparakis M; Ragoussis J; Udalova IA, 2014, 'IRF5:RelA interaction targets inflammatory genes in macrophages', Cell Reports, 8, pp. 1308 - 1317,

delFresno C; Soulat D; Roth S; Blazek K; Udalova I; Sancho D; Ruland J; Ardavín C, 2013, 'Interferon-β Production via Dectin-1-Syk-IRF5 Signaling in Dendritic Cells Is Crucial for Immunity to C.albicans', Immunity, 38, pp. 1176 - 1186,

Ryzhakov G; Teixeira A; Saliba D; Blazek K; Muta T; Ragoussis J; Udalova IA, 2013, 'Cross-species analysis reveals evolving and conserved features of the nuclear factor κb (NF-κB) proteins', Journal of Biological Chemistry, 288, pp. 11546 - 11554,

Weiss M; Blazek K; Byrne AJ; Perocheau DP; Udalova IA, 2013, 'IRF5 is a specific marker of inflammatory macrophages in vivo', Mediators of Inflammation, 2013,

Ryzhakov G; Blazek K; Lai CCK; Udalova IA, 2012, 'IL-17 receptor adaptor protein Act1/CIKS plays an evolutionarily conserved role in antiviral signaling', Journal of Immunology, 189, pp. 4852 - 4858,

Luron L; Saliba D; Blazek K; Lanfrancotti A; Udalova IA, 2012, 'FOXO3 as a new IKK-ε-controlled check-point of regulation of IFN-β expression', European Journal of Immunology, 42, pp. 1030 - 1037,

Ryzhakov G; Blazek K; Lai CC-K; Udalova IA, 2012, 'O011 IL-17 receptor adaptor Act1/CIKS plays an evolutionarily conserved role in antiviral signalling', Cytokine, 59, pp. 501 - 502,

Ryzhakov G; Lai CCK; Blazek K; To KW; Hussell T; Udalova I, 2011, 'IL-17 boosts proinflammatory outcome of antiviral response in human cells', Journal of Immunology, 187, pp. 5357 - 5362,

Ryzhakov G; Blazek K; Udalova IA, 2011, 'Evolution of vertebrate immunity: Sequence and functional analysis of the SEFIR domain family member Act1', Journal of Molecular Evolution, 72, pp. 521 - 530,

Krausgruber T; Blazek K; Smallie T; Alzabin S; Lockstone H; Sahgal N; Hussell T; Feldmann M; Udalova IA, 2011, 'IRF5 promotes inflammatory macrophage polarization and T H1-TH17 responses', Nature Immunology, 12, pp. 231 - 238,

Lee HJ; Hinshelwood R; Bouras T; Gallego-Ortega D; Valdes-Mora F; Blazek K; Visvader JE; Clark SJ; Ormandy CJ, 2011, 'Lineage specific methylation of the Elf5 promoter in mammary epithelial cells', Stem Cells, 29, pp. 1611 - 1619,

Krausgruber T; Saliba D; Eames H; Williams L; Smallie T; Blazek K; Udalova IA, 2011, 'PS2-062. Novel role of IRF5 in transcriptional inhibition of human IL-10 gene expression', Cytokine, 56, pp. 81 - 81,

Krausgruber T; Saliba D; Ryzhakov G; Lanfrancotti A; Blazek K; Udalova IA, 2010, 'IRF5 is required for late-phase TNF secretion by human dendritic cells', Blood, 115, pp. 4421 - 4430,

Ryzhakov G; Lai C; Blazek K; Udalova I, 2010, 'PS1-75 IL-17 stimulation results in a pro-inflammatory outcome during antiviral response in human cells', Cytokine, 52, pp. 33 - 33,

Krausgruber T; Saliba D; Blazek K; Lockstone H; Sahgal N; Alzabin S; Teixeira A; Hussell T; Ragoussis J; Udalova IA, 2010, 'SS5-2 IRF5 as a defining factor of M1 macrophage polarization', Cytokine, 52, pp. 44 - 44,

Hilton HN; Kalyuga M; Cowley MJ; Alles MC; Lee HJ; Caldon CE; Blazek K; Kaplan W; Musgrove EA; Daly RJ; Naylor MJ; Graham J; Clarke C; Ormandy CJ, 2010, 'The antiproliferative effects of progestins in T47D breast cancer cells are tempered by progestin induction of the ETS transcription factor Elf5', Molecular Endocrinology, 24, pp. 1380 - 1392,

Oakes SR; Naylor MJ; Asselin-Labat M; Blazek K; Gardiner-Garden M; Hilton HN; Kazlauskas M; Pritchard M; Chodosh L; Pfeffer P; Lindeman GJ; Visvader J; Ormandy CJ, 2008, 'The Ets transcription factor Elf5 specifies mammary alveolar cell fate', Genes and Development, 22, pp. 581 - 586,

Craven AJ; Nixon AJ; Ashby MG; Ormandy CJ; Blazek K; Wilkins RJ; Pearson AJ, 2006, 'Prolactin delays hair regrowth in mice', Journal of Endocrinology, 191, pp. 415 - 425

Harris J; Stanford PM; Sutherland K; Oakes SR; Naylor MJ; Robertson F; Blazek K; Kazlauskas M; Hilton HN; Wittlin S; Alexander WS; Lindeman GJ; Visvader J; Ormandy CJ, 2006, 'Socs2 and Elf5 mediate prolactin-induced mammary gland development', Molecular Endocrinology, 20, pp. 1177 - 1187

Naylor MJ; Oakes SR; Gardiner-Garden M; Harris J; Blazek K; Ho TW; Li F; Wynick D; Walker AM; Ormandy CJ, 2005, 'Transcriptional changes underlying the secretory activation phase of mammary gland development', Molecular Endocrinology, 19, pp. 1868 - 1883

Faedo M; Ford CE; Mehta R; Blazek K; Rawlinson WD, 2004, 'Mouse mammary tumor like virus is associated with p53 nuclear accumulation and progesterone receptor positivity but not estrogen positivity in human female breast cancer', Clinical Cancer Research, 10, pp. 4417 - 4419

Back to profile page